Cognisant Announced That It Is Working With Boehringer Ingelheim To Advance The Speed And Quality Of Medicinal Therapy Development.Leveraging The Veeva Development Cloud, Cognisant Will Help Boehringer Ingelheim To Unify Medicinal Development Processes And Data Into A Connected Technology Ecosystem, Enhancing Collaboration Across Clinical, Regulatory, And Quality Functions.Achieving An End-To-End Platform To Help Speed The Development Of Life-Changing Therapies Has Been An Elusive Goal For Many Organisations. This Collaboration With Cognisant And Veeva Will Empower To Advance This Important Programme That Will Positively Impact Patient Lives.Collaborating With Veeva, Cognisant Is Now Implementing Services, Which Include Programme Management, System Architecture And Design, Training, Data Migration, Integration, Testing And Validation Services. Working Together Will Set New Precedents For The Interaction Of Clinical, Regulatory And Quality Functions To Accelerate The Delivery Of New Life-Saving Treatments.
